Yamazaki T, Maruoka S, Sakamoto K
Department of Radiology, Tohoku University School of Medicine.
Kaku Igaku. 1995 Nov;32(11):1199-206.
99mTc-mercaptoacetyltriglycine (MAG3) is a new agent for dynamic renal scintigraphy. It provides not only superior quality of imaging to conventional agents such as 131I-orthoiodohippurate or 99mTc-demethylenetriaminepantaacetic acid but also quantification of renal function as do the latter agents. The aim of the present study was to evaluate the value of the tubular extraction rate (TER) using 99mTc-MAG3 calculated by Bubeck's method, a simple technique for quantifying renal function. In 31 patients with renal disorders, we compared the TER thus obtained with laboratory data, plasma paraaminohippurate clearance, effective renal plasma flow calculated by Tauxe's method, and plasma 99mTc-MAG3 clearance calculated according to the two-compartment model. TER was easily applicable in clinical settings, and showed close parallels with the other indexes of renal function. We believe, therefore, that it can serve as a useful parameter of renal function.
99m锝-巯基乙酰三甘氨酸(MAG3)是一种用于动态肾闪烁显像的新型药物。它不仅能提供比传统药物(如131I-邻碘马尿酸盐或99m锝-二巯基丁二酸)更高质量的图像,还能像后两者一样对肾功能进行定量分析。本研究的目的是评估使用Bubeck方法计算的99m锝-MAG3肾小管提取率(TER)的价值,Bubeck方法是一种定量肾功能的简单技术。在31例肾脏疾病患者中,我们将由此获得的TER与实验室数据、血浆对氨基马尿酸清除率、用Tauxe方法计算的有效肾血浆流量以及根据二室模型计算的血浆99m锝-MAG3清除率进行了比较。TER在临床环境中易于应用,并且与其他肾功能指标密切相关。因此,我们认为它可作为肾功能的一个有用参数。